TerSera Therapeutics LLC
TerSera Therapeutics LLC has 1 FDA recall, 1 inspection, 0 510(k) clearances and 0 compliance actions on record.
- Latest recall
- D-0875-2026 · Class II · Aug 31, 2026
- Latest inspection
- Oct 5, 2023 · NAI
Reviewing TerSera Therapeutics LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or get TerSera Therapeutics LLC's full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site, in Claude, Cursor or ChatGPT.
Summary
- Recalls
- 1
- 510(k) Clearances
- 0
- Inspections
- 1
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0875-2026 | Class II | Zoladex (goserelin) implant, 3.6 mg, One single-Use Syringe packaged in a carton, Rx only… | Aug 31, 2026 |
Recent FDA Inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Oct 5, 2023 | Deerfield, IL | Drugs | No Action Indicated (NAI) | 3016527790 |